BHVN
Biohaven Pharmaceutical Holding Co Ltd
NYSE: BHVN · HEALTHCARE · BIOTECHNOLOGY
$9.59
+4.24% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.86
Dividend yield
—
52W range
$7 – $24
Volume
2.2M
Biohaven Pharmaceutical Holding Co Ltd (BHVN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-310.70%
ROA
-83.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | — | — | — | — |
| 2019 | — | $-528.80M | — | — | — |
| 2020 | $0.00 | $-118.67M | — | — | — |
| 2021 | $462.51M | $-213.80M | 80.18% | -47.33% | -46.23% |
| 2022 | $0.00 | $-570.28M | — | — | — |
| 2023 | $0.00 | $-408.17M | — | — | — |
| 2024 | $0.00 | $-846.42M | — | — | — |
| 2025 | $0.00 | $-738.82M | — | — | — |